We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KAHC.U
151
DELISTED
KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant
KAHC.U
| $30M | 0.14% |
+2,999,500
| New | +$30M |
|
152
Deckers Outdoor
DECK
$13.3B
| $29.9M | 0.14% |
542,178
+416,802
| +332% | +$22.2M |
|
|
MXIM
153
DELISTED
Maxim Integrated Products
MXIM
| $29.7M | 0.14% |
325,067
-143,112
| -31% | -$13.1M |
|
154
PUT
Tesla
TSLA
$1.24T
| $29.6M | 0.14% |
+132,900
| New | +$33.4M |
|
155
McDonald's
MCD
$188B
| $29.5M | 0.14% |
131,583
-131,594
| -50% | -$28.1M |
|
156
International Flavors & Fragrances
IFF
$19.4B
| $29.3M | 0.13% |
209,817
+61,828
| +42% | +$8M |
|
157
CALL
iShares MSCI Emerging Markets ETF
EEM
$28B
| $29.1M | 0.13% |
545,700
+377,700
| +225% | +$20.7M |
|
|
ESPR
158
DELISTED
Esperion Therapeutics
ESPR
| $28.9M | 0.13% |
1,029,701
-346,229
| -25% | -$10.2M |
|
159
Newmont
NEM
$98.2B
| $28.8M | 0.13% |
478,452
+471,763
| +7,053% | +$28.2M |
|
|
NVTA
160
DELISTED
Invitae Corporation
NVTA
| $28.8M | 0.13% |
752,679
-295,670
| -28% | -$13.4M |
|
161
Etsy
ETSY
$7.65B
| $28.7M | 0.13% |
142,264
+10,860
| +8% | +$2.27M |
|
162
Ford
F
$57.3B
| $28.5M | 0.13% |
+2,329,310
| New | +$26.7M |
|
163
Zoom
ZM
$25.8B
| $28.3M | 0.13% |
+88,198
| New | +$32.5M |
|
|
ASZ.U
164
DELISTED
Austerlitz Acquisition Corporation II Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
ASZ.U
| $28.1M | 0.13% |
+2,803,374
| New | +$28.4M |
|
165
JetBlue
JBLU
$1.96B
| $27.9M | 0.13% |
1,371,650
-72,988
| -5% | -$1.26M |
|
|
TXNM
166
TXNM Energy Inc
TXNM
$6.47B
| $27.5M | 0.13% |
561,488
+447,354
| +392% | +$21.7M |
|
167
PUT
Apple
AAPL
$4.89T
| $27.5M | 0.13% |
+224,900
| New | +$28.9M |
|
|
DOCU
168
DocuSign
DOCU
$9.63B
| $27.4M | 0.13% |
135,424
+131,113
| +3,041% | +$30.4M |
|
169
PepsiCo
PEP
$186B
| $27.1M | 0.12% |
+191,521
| New | +$26.3M |
|
170
Vornado Realty Trust
VNO
$7.47B
| $27M | 0.12% |
594,709
+364,083
| +158% | +$15.1M |
|
171
Ternium
TX
$9.29B
| $26.8M | 0.12% |
690,555
-35,501
| -5% | -$1.14M |
|
172
PUT
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $26.2M | 0.12% |
240,400
+113,700
| +90% | +$12.7M |
|
173
Wells Fargo
WFC
$261B
| $26.1M | 0.12% |
667,362
-1,132,414
| -63% | -$40.1M |
|
174
NIO
NIO
$11.3B
| $25.9M | 0.12% |
664,704
+326,088
| +96% | +$16.6M |
|
175
Darling Ingredients
DAR
$9.93B
| $25.9M | 0.12% |
351,921
-286,158
| -45% | -$19.7M |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.